Terumo Corporation (TRUMF)

Market Cap	29.10B
Revenue (ttm)	6.89B
Net Income (ttm)	834.03M
Shares Out	n/a
EPS (ttm)	0.56
PE Ratio	n/a
Forward PE	n/a
Dividend	0.15 (0.69%)
Ex-Dividend Date	Mar 28, 2024

Volume	133
Open	18.65
Previous Close	20.45
Day's Range	18.65 - 20.58
52-Week Range	15.00 - 22.26
Beta	0.45
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1921
• Employees: 30,591
• Stock Exchange: OTCMKTS
• Ticker Symbol: TRUMF

Financial Performance

In 2023, Terumo's revenue was 921.86 billion, an increase of 12.39% compared to the previous year's 820.21 billion. Earnings were 106.37 billion, an increase of 19.09%.

Financial numbers in JPY